aTYR PHARMA INC (ATYR) Operating margin 2019–2025
aTYR PHARMA INC (ATYR) operating margin by fiscal year — reported operating income divided by reported revenue.
-40856.3%FY2025 · since FY2019: -5445.0% → -40856.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -40856.3% | -11956.7 pp |
| FY2024 | -28899.6% | -13341.8 pp |
| FY2023 | -15557.8% | -15111.0 pp |
| FY2022 | -446.8% | — |
| FY2020 | -152.2% | +5292.8 pp |
| FY2019 | -5445.0% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ATYR financial trends
ATYR RevenueATYR Net incomeATYR Net marginATYR Gross profitATYR Gross marginATYR Operating incomeATYR Operating cash flowATYR Free cash flowATYR Capital expendituresATYR Return on equityATYR Stock buybacksATYR Dividends paidATYR Total assetsATYR Total liabilitiesATYR Shareholders’ equityATYR overview →